Ozempic and Wegovy are selected for Medicare's price negotiations
geox Friday, January 17, 2025
Summary
The article discusses the Biden administration's efforts to lower drug prices, including allowing Medicare to negotiate prices with pharmaceutical companies and capping insulin costs. It compares these measures to the Trump administration's approach, which focused on increasing competition and transparency in the drug market.
65
54
Summary
apnews.com